Skip to main content
Clinical Trials/NCT00551837
NCT00551837
Completed
Not Applicable

Immune Response to Influenza Vaccination

The Cleveland Clinic0 sites82 target enrollmentNovember 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Solid Organ Transplantation
Sponsor
The Cleveland Clinic
Enrollment
82
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the immune response to a routine influenza vaccination. Influenza vaccination is given as part of routine standard of care in these individuals and is not part of the study protocol. The study will evaluate for a change in response to common antigens over time after influenza vaccination to determine if changes are related to the development of chronic rejection after solid-organ transplantation. We hypothesize that the influenza vaccine contributes to the alloreactivity of T cells verses common HLA types in the donor pool.

Registry
clinicaltrials.gov
Start Date
November 2006
End Date
May 2008
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Transplant recipients (lung or kidney) 18 years or older, more than 3 months after transplantation
  • Transplant candidates (kidney) 18 years or older, to recieve influenza vaccination
  • Healthy volunteers to receive influenza vaccination

Exclusion Criteria

  • Under 18 years of age
  • Medical contraindication for vaccine
  • Transplant recipients receiving acute rejection therapy within one month
  • Healthy volunteers with autoimmune disease or medications to mediate immune function
  • Receipt of live, attenuated influenza vaccine, instead of injectable vaccine

Outcomes

Primary Outcomes

Not specified

Similar Trials